FDA gives tentative approval to Merck's injectable insulin glargine | Study links diabetes to higher hospital readmission | Researchers suggest routine screening for erectile dysfunction in diabetes
July 21, 2017
DiabetesPro SmartBrief
News for diabetes health professionals
Diabetes in Focus
FDA gives tentative approval to Merck's injectable insulin glargine
Merck announced that LUSDUNA Nexvue, its injectable insulin glargine, has only received tentative approval from the FDA because of a lawsuit filed by Sanofi last September arguing Merck's drug infringes on its patent for Lantus. Merck will have to wait up to 30 months, or if a court rules in its favor, before the FDA can issue a final approval for the drug.
MedPage Today (free registration) (7/20) 
LinkedIn Twitter Facebook Google+ Email
Study links diabetes to higher hospital readmission
Researchers found that University of Michigan Health System's hospital readmission rate for patients with diabetes was 26%, compared with 22% among those without the condition. The findings in Clinical Diabetes and Endocrinology were based on an analysis of data for 7,763 patients.
Endocrinology Advisor (7/19) 
LinkedIn Twitter Facebook Google+ Email
Researchers suggest routine screening for erectile dysfunction in diabetes
Men with diabetes should be screened for erectile dysfunction as part of a routine assessment of their cardiovascular health, according to a study in Diabetic Medicine. French researchers conducted a meta-analysis of 145 studies involving 88,577 men with a mean age of 56 and found a higher prevalence of erectile dysfunction among those with type 2 diabetes than men with type 1 diabetes, and that the risk of the condition increased after age 60.
Medscape (free registration) (7/20) 
LinkedIn Twitter Facebook Google+ Email
Nutrition & Wellness
Sedentary behavior tied to insulin therapy-related weight gain in diabetes
A study in Diabetes Care showed that patients with type 2 diabetes and a body mass index of less than 30 kg/m2 tended to experience an increase in mean body weight and waist circumference 12 months after starting insulin therapy, while those who had a BMI of 30 kg/m2 or higher did not, and the authors believe increased sedentary behavior explains the findings. Researchers studied 40 diabetes patients and found that although there was a decline in fasting glucose and A1C levels among those with a BMI of less than 30 kg/m2, there was also a decrease in steps per day and other markers of physical activity.
Medscape (free registration) (7/19) 
LinkedIn Twitter Facebook Google+ Email
Healthy lifestyle reduces pregnancy risks, research shows
Healthy diet and exercise habits during pregnancy reduced gestational diabetes risk by 24% and cesarean-section delivery risk by about 10%, researchers said. The review of 36 studies, published in The BMJ, found a healthy lifestyle also reduced the risk of excessive weight gain during pregnancy.
HealthDay News (7/19) 
LinkedIn Twitter Facebook Google+ Email
Study questions value of structured exercise for older adults
Older adults who participated in a structured exercise program showed a small reduction in total sedentary time but not in sedentary periods of an hour or longer, experts wrote in a research letter published in the Journal of the American Medical Association. Researchers said it was not clear if the reductions, which were compared with results from a group of older adults in a basic health education program, were clinically significant.
Medscape (free registration) (7/18) 
LinkedIn Twitter Facebook Google+ Email
Practice Update
AHA warns "poorly designed" MU Stage 3 requirements would affect patient care
The CMS' proposed Medicare Outpatient Prospective Payment System rule for 2018 is "poorly designed" and does not "propose relief" from the Meaningful Use Stage 3 reporting requirements, which could "do real damage to patients' access to care," according to the American Hospital Association. "The mandate for all hospitals and critical access hospitals to switch to new EHR functionality and report for a full year is unattainable and is at odds with the meaningful use flexibility proposed for eligible clinicians in the Quality Payment Program proposed rule," wrote AHA Executive Vice President Tom Nickels.
Becker's Health IT & CIO Review (7/18) 
LinkedIn Twitter Facebook Google+ Email
ONC says improvements needed in patient access to health records
ONC says improvements needed in patient access to health records
(John Moore/Getty Images)
Health care organizations should coordinate better care and reduce consumer burden by improving their processes for patient data access measures, according to the Office of the National Coordinator for Health IT's "Improving the Health Records Request Process for Patients" report. The agency recommends allowing patients to request and receive records through their patient portal or another electronic means; improving usability with e-verification, plain language instructions and status updates; and encouraging patients to use portals by promoting easy services such as online appointment-scheduling.
Health IT Security (7/19) 
LinkedIn Twitter Facebook Google+ Email
Trends & Technology
Heart disease tops list of most costly chronic diseases
CDC figures show that cardiovascular disease is the most expensive chronic illness, at an annual cost of $317 billion -- $193.7 billion for direct care and $123.5 billion in lost productivity -- followed by smoking- and alcohol-related conditions, which account for more than $300 billion and $249 billion, respectively. Diabetes, Alzheimer's disease, cancer, obesity, arthritis, asthma and stroke round out the top 10.
Health Payer Intelligence (7/19) 
LinkedIn Twitter Facebook Google+ Email
CBO: 32M Americans would lose insurance under repeal without replacement
CBO: 32M Americans would lose insurance under repeal without replacement
(Alex Wong/Getty Images)
President Donald Trump pushed Senate Republicans to revisit their plan to simultaneously repeal and replace portions of the Affordable Care Act rather than pursue a straight repeal, an approach that the Congressional Budget Office estimates would cause 32 million Americans to lose insurance coverage by 2026, compared with 23 million under the American Health Care Act and 22 million under the Better Care Reconciliation Act. The Obamacare Repeal Reconciliation Act of 2017 would also nearly double premiums by 2026 and compel insurers to exit individual markets as soon as next year, the analysis found.
Reuters (7/19),  The Hill (7/19),  HuffPost (7/20) 
LinkedIn Twitter Facebook Google+ Email
Nothing great in the world has been accomplished without passion.
Georg Wilhelm Friedrich Hegel,
LinkedIn Twitter Facebook Google+ Email
Learn more about DiabetesPro:
DiabetesPro Home | Professional Education | Journals
Research Grants | Recognition Programs | Membership
Sign Up
SmartBrief offers 200+ newsletters
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Wynn Hansen
P: 202.470.1149
Partner Relations Manager  -  Lauren Barr
Editor  -  Kathryn Doherty
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2017 SmartBrief, Inc.®
Privacy policy |  Legal Information